Mountain View, CA (PRWEB) December 10, 2013
Vendavo, the leading provider of enterprise solutions to analyze, negotiate and close profitable deals, announced today that it has received a rating of “strong positive” for the second year in a row in Gartner’s “MarketScope for Price Optimization and Management Software for B2B: 2013" report, published November 25.
Vendavo received the highest rating possibly given based on specific criteria, including Market Presence, Technology, Price Analysis, Price Optimization and Price Execution. This rating reflects the high value Vendavo’s solutions bring to P&L owners, finance, marketing and sales teams by delivering increased profit margins and revenue. Gartner analyzed nine companies in the price optimization marketplace for the report.
“It’s not only gratifying but also validating that Gartner has granted us a strong rating and recognition as an industry leader, as this mirrors consistent feedback from our Fortune 500 customers,” said Neil Lustig, Vendavo CEO. “We’ve made serious strides this year in delivering innovation that allows our customers to harness their enterprise data to drive higher profit. We will continue this upward momentum by pushing higher value for B2B companies with the best profit optimization solution in the industry.”
The MarketScope report finds “…price optimization has shown steady growth during the past two to three years and has found its way onto the CXO's agenda, aligning closely with executive priorities of revenue generation, customer acquisition and profit/margin improvement.” This confirms what Vendavo has strongly maintained since the company’s inception: profit optimization solutions are a source of significant competitive advantage.
Other key findings from the report include the following:
- Price optimization and management solutions provide significant value in their ability to positively influence margins, revenue and profitability. “A successful PO&M implementation can increase margins by 50 basis points or more, and increase revenue by 2% to 4%.”
- Big data, data visualization tools and configure/price/quote (CPQ) suites were identified by the surveyed Gartner customers as a major priority for the next three to five years.
- It is no longer feasible to manage price optimization in spreadsheets and database tools with the increased innovation in analytic, data and application tools used in PO&M.
This Gartner report punctuates the most successful commercial year to date for Vendavo. Throughout 2013, the company consistently secured contracts in two out of every three competitive engagements. Additionally, the company managed $207 billion in customer revenue and increased annual profits by $2.3 billion.
To download Gartner’s “MarketScope for Price Optimization and Management for B2B: 2013” report, click here: http://www.vendavo.com/newresources/marketscope-price-optimization-management-software-b2b-2013/.
Follow Vendavo on Twitter at @vendavo.
Visit Vendavo on LinkedIn at http://www.linkedin.com/company/vendavo.
Visit Vendavo on Facebook at http://www.facebook.com/company/vendavo.
Vendavo’s front-line profit optimization solutions help customers sell more profitably by empowering salespeople to negotiate confidently at the “Moment of Truth,” delivering 10-30 percent incremental profit, while increasing front-line effectiveness, agility and responsiveness. Vendavo is the enterprise profitability solution of choice for more than 300 company divisions at some of the world’s biggest names in Chemicals and Process Industries, Consumer Packaged Goods, Wholesale Distribution, Energy and Utilities, Technology, Industrial Manufacturing, and Medical Devices and Consumables.
Gartner does not endorse any vendor; product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.